Skip to main content
Equibles

MORGAN STANLEY

Position in SLS — SELLAS Life Sciences Group, Inc.

CIK 895421 NEW YORK, NY
Back to SLS Full portfolio

Position in SLS

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$18,247,210
+$12,594,694 QoQ
Shares Held
1,236,261
-7.5% QoQ
Ownership
0.612%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#12
of 192 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 44% Shared 0% None 56%

Common Shares in SLS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. SLS ranks #105 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in SLS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $18,247,210 1,236,261
2026-03-31 $5,652,516 1,336,293
2025-12-31 $3,358,800 890,929
2025-09-30 $1,698,211 1,054,791
2025-06-30 $2,375,005 1,084,478
2025-03-31 $71,765 66,450
2024-12-31 $16,409 15,778
2024-09-30 $21,793 17,435
2024-06-30 $3,923 3,297
2024-03-31 $1,434 1,420
2023-12-31 $1,505 1,420
2023-09-30 $3,968 2,420
2023-06-30 $13,219 8,420
2023-03-31 $7,722 5,400
2022-12-31 $131,116 55,558
2022-09-30 $107,918 53,425
2022-06-30 $203,979 91,471
2022-03-31 $609,876 91,299
2021-12-31 $686,460 124,134
2021-09-30 $1,693,390 184,868
2021-06-30 $172,038 15,499
2021-03-31 $33,306 3,900
2020-12-31 $9,586 1,650
2020-09-30 $7,512 2,835
2020-06-30 $8,979 3,065
2020-03-31 $60,369 34,896